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To the Editor: Lehman and Guercio conclude that the U.S. Medical Licensing Examination (USMLE) Step 2 Clinical Skills (CS) exam produces a poor return on investment. Their computation is based on the explicit costs of the exam to students. They evaluate the benefits only in terms of screening out unqualified applicants. Lehman and Guercio do not consider that requiring passage of Step 2 CS has also compelled medical schools to bolster clinical-skills education in their curricula.
Every exam should correspond to educational activities in which students learn the knowledge and skills needed to pass that exam. 1 Delivering a preparatory curriculum for licensure exams is an ethical obligation for medical schools. A substantial benefit of Step 2 CS stems from curricular innovations that medical schools have made to prepare students for the exam. Contemporary curricula include instruction in fundamental clinical skills and inculcation of the importance of those skills.
An investment cannot be measured exclusively by its cost, but rather, the cost must be balanced against the benefit realized from the expenditure. In this case, Lehman and Guercio discounted the value of the curriculum innovations that occurred in response to the imposition of Step 2 CS. Hugh A. Stoddard, Ph.D.
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The Authors Reply: Huwendiek et al. argue that the USMLE Step 2 CS exam "filter[s] out candidates in need of remediation." As shown, because of the high pass rates, the exam annually filters out only 32 candidates who fail the exam twice. Since candidates may take the exam six times, 1 Step 2 CS only delays -but does not filter out -the practice of medicine by any future physician. Furthermore, we question the notion that "without a mandatory high-stakes clinical skills exam, too many new graduates may lack the clinical skills deemed critical to effective health care." This statement incorrectly implies that passing a high-stakes clinical exam ensures a sufficient level of clinical skills. This belief is as Overall, 17 of the 49 patients (35%) had viremia at some time. Ten of 26 patients in whom treatment was initiated had viremia; 4 were seronegative (antibody titer, <2560) and 6 were seropositive (antibody titer, ≥2560). 1 Of these patients, 4 had viremia at baseline and 3 were seropositive. Seven of 23 patients who received more than 24 infusions had viremia and 2 were seronegative. One blood sample was obtained from each of the 18 healthy volunteers; 6 were seronegative, 12 were seropositive, and none had detectable viral DNA.
Fisher's exact test was used to determine a statistical difference between the treated patients who had viremia and healthy volunteers (P = 0.003) ( Table 1) . We observed a range in viral titers from 13 to 510 copies of JC virus DNA per milliliter (mean, 43 copies per milliliter) in patients in the initial year of treatment and from 21 to 126 copies (mean, 40 copies per milliliter) in those who received more than 24 infusions. Of the 17 persons with viremia, 11 were seropositive (65%) and 6 were seronegative (35%).
Although viremia by itself is not a predictor of the risk of PML, the observation that viremia
